from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1939/-

LFCtreatmentdescriptionclass of inhibitor

-0.216

Amikacinug/mL Amikacintranslation

-0.407

Cap5-10ug/mL Capreomycintranslation

-0.542

Rox10-50 ug/mL Roxithromycintranslation

0.484

SM2-5 ug/mL Streptomycintranslation

0.120

Tet5-10 ug/mL Tetracyclinetranslation

-0.597

Rif0.2-5ug/mL Rifampicintranscription

-0.011

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.004

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.843

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.336

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.036

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.189

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.187

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.782

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.779

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.224

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.555

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.140

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.912

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.171

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.926

KCN5-20 ug/mL Potassium cyaniderespiration

0.776

NaN30.2-2 mM Sodium aziderespiration

-0.564

Nigericin50 uM Nigericinrespiration

0.029

TRC10-150 ug/mL Triclosanrespiration

-0.567

TRZ10-25 ug/mL Thioridazinerespiration

0.398

Valinomycin0.5-10 uM Valinomycinrespiration

0.471

ZnSO42 mM ZnSO4respiration

0.358

menadione6-10 ug/mL Menadionerespiration

0.971

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.138

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.197

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.671

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.361

NRP_1Non-replicating persistence stage 1dosRassociated

-0.250

Amp0.2mg/mL AmpicillincellWall

-0.352

Cephalexin20-100 ug/mL CephalexincellWall

-0.329

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.537

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.430

EMB10-20 ug/mL EthambutolcellWall

0.172

Eta12-40 ug/mL EthionamidecellWall

0.395

INH0.2-0.4 ug/mL IsoniazidcellWall

0.125

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.769

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.878

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.434

BZA0.12 mg/mL BenzamidearomaticAmides

-0.688

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.263

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.363

H2O24 mM hydrogen peroxideDNAdamaging

-0.043

Levo10 ug/mL LevofloxacinDNAdamaging

-0.962

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.366

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.037

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.453

UVUV-irradiationDNAdamaging

0.865

ARP41-4 ug/mL Antitubercular compound ARP4?

0.097

Antimycin12.5-50 ug/mL Antimycin A?

-0.189

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.049

PA_110-50 ug/mL Antitubercular compound PA-1?

0.093

PA_2110-50 ug/mL Antitubercular compound PA-21?

3.191

PA8240.2-2 ug/mL PA-824?

2.036

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.935

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.468

Verapamil50 uM Verapamil?

-0.110

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.769

methoxatin10-20 ug/mL Methoxatin?